Advertisement

Picture Berlin Partner Top News Bayer Aignostics Collaboration 650x100px
Organisation › Details

Monte Rosa Therapeutics AG

Period Start 2018-01-01 established
  Group Monte Rosa Therapeutics (Group)
Products Industry protein degradation drug
  Industry 2 protein degradation technology
Person Person Warmuth, Markus (Monte Rosa Therapeutics 202009 CEO + Venture Partner at Versant Ventures before Eisai/H3 Biomedicine)
     
Region Region Basel BS
  Country Switzerland
  Street 36 Aeschenvorstadt
Labs at Technologiepark, Hochbergerstr. 60C, 4057 Basel
  City 4051 Basel
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
     
   
Record changed: 2023-07-10

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Monte Rosa Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top